Search for clinical, genetic, morphological and immunohistochemical predictors of parathyroid cancer recurrence

Background. Currently, there is no consensus on postoperative risk stratification for parathyroid cancer (PC). The risk factors of disease progression are crucial for choosing the optimal treatment strategy, including adjuvant methods and patient,s follow-up. Aim. Identifying predictors of PC rec...

Full description

Saved in:
Bibliographic Details
Main Authors: Ekaterina I. Kim, Anna K. Eremkina, Alina R. Elfimova, Natalia G. Mokrysheva
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2024-12-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/633463/pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832592268230393856
author Ekaterina I. Kim
Anna K. Eremkina
Alina R. Elfimova
Natalia G. Mokrysheva
author_facet Ekaterina I. Kim
Anna K. Eremkina
Alina R. Elfimova
Natalia G. Mokrysheva
author_sort Ekaterina I. Kim
collection DOAJ
description Background. Currently, there is no consensus on postoperative risk stratification for parathyroid cancer (PC). The risk factors of disease progression are crucial for choosing the optimal treatment strategy, including adjuvant methods and patient,s follow-up. Aim. Identifying predictors of PC recurrence Materials and methods. We performed a retrospective observational study of 85 patients with verified PC divided into remission (n=61) and recurrence (n=19) groups after primary surgical treatment for the period 2004–2023. The analyzed parameters included demographic, laboratory and instrumental data of patients with PC, the presence of a mutation in the CDC73 gene, morphological and immunohistochemical characteristics of the primary tumor. Results. After adjustments for multiple comparisons, a statistically significant association of recurrence was found for preoperative calcium level (p0.001), pT4 stage (p0.001) according to TNM-classification (Tumor, Nodus, Metastasis) American Joint Committee on Cancer 2017. There was a statistical trend for calcium correction for hypoalbuminemia (p=0.002), presence of nephrolithiasis/nephrocalcinosis (p=0.021), parathyroid hormone level 6 months after primary surgery (p0.05), pT3 stage TNM (p=0.007), nuclear expression of parafibromin in tumor tissue (p0.05). We did not reveal any associations between disease recurrence and sex, age, volume of surgical treatment, germline mutation in the CDC73, parafibromin expression and Ki-67 in tumor tissue. Conclusion. Our study revealed several factors of poor prognosis, allowing to identify a risk group for recurrence, which can contribute to active dynamic monitoring and timely treatment.
format Article
id doaj-art-1f1c210521bf4d37a8c8852117b1173c
institution Kabale University
issn 0040-3660
2309-5342
language Russian
publishDate 2024-12-01
publisher "Consilium Medicum" Publishing house
record_format Article
series Терапевтический архив
spelling doaj-art-1f1c210521bf4d37a8c8852117b1173c2025-01-21T11:09:17Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422024-12-01961095896710.26442/00403660.2024.10.20287278565Search for clinical, genetic, morphological and immunohistochemical predictors of parathyroid cancer recurrenceEkaterina I. Kim0https://orcid.org/0000-0001-7879-8495Anna K. Eremkina1https://orcid.org/0000-0001-6667-062XAlina R. Elfimova2https://orcid.org/0000-0001-6935-3187Natalia G. Mokrysheva3https://orcid.org/0000-0002-9717-9742Endocrinology Research CenterEndocrinology Research CenterEndocrinology Research CenterEndocrinology Research CenterBackground. Currently, there is no consensus on postoperative risk stratification for parathyroid cancer (PC). The risk factors of disease progression are crucial for choosing the optimal treatment strategy, including adjuvant methods and patient,s follow-up. Aim. Identifying predictors of PC recurrence Materials and methods. We performed a retrospective observational study of 85 patients with verified PC divided into remission (n=61) and recurrence (n=19) groups after primary surgical treatment for the period 2004–2023. The analyzed parameters included demographic, laboratory and instrumental data of patients with PC, the presence of a mutation in the CDC73 gene, morphological and immunohistochemical characteristics of the primary tumor. Results. After adjustments for multiple comparisons, a statistically significant association of recurrence was found for preoperative calcium level (p0.001), pT4 stage (p0.001) according to TNM-classification (Tumor, Nodus, Metastasis) American Joint Committee on Cancer 2017. There was a statistical trend for calcium correction for hypoalbuminemia (p=0.002), presence of nephrolithiasis/nephrocalcinosis (p=0.021), parathyroid hormone level 6 months after primary surgery (p0.05), pT3 stage TNM (p=0.007), nuclear expression of parafibromin in tumor tissue (p0.05). We did not reveal any associations between disease recurrence and sex, age, volume of surgical treatment, germline mutation in the CDC73, parafibromin expression and Ki-67 in tumor tissue. Conclusion. Our study revealed several factors of poor prognosis, allowing to identify a risk group for recurrence, which can contribute to active dynamic monitoring and timely treatment.https://ter-arkhiv.ru/0040-3660/article/viewFile/633463/pdfprimary hyperparathyroidismparathyroid cancerdisease-free survivaldiagnostics
spellingShingle Ekaterina I. Kim
Anna K. Eremkina
Alina R. Elfimova
Natalia G. Mokrysheva
Search for clinical, genetic, morphological and immunohistochemical predictors of parathyroid cancer recurrence
Терапевтический архив
primary hyperparathyroidism
parathyroid cancer
disease-free survival
diagnostics
title Search for clinical, genetic, morphological and immunohistochemical predictors of parathyroid cancer recurrence
title_full Search for clinical, genetic, morphological and immunohistochemical predictors of parathyroid cancer recurrence
title_fullStr Search for clinical, genetic, morphological and immunohistochemical predictors of parathyroid cancer recurrence
title_full_unstemmed Search for clinical, genetic, morphological and immunohistochemical predictors of parathyroid cancer recurrence
title_short Search for clinical, genetic, morphological and immunohistochemical predictors of parathyroid cancer recurrence
title_sort search for clinical genetic morphological and immunohistochemical predictors of parathyroid cancer recurrence
topic primary hyperparathyroidism
parathyroid cancer
disease-free survival
diagnostics
url https://ter-arkhiv.ru/0040-3660/article/viewFile/633463/pdf
work_keys_str_mv AT ekaterinaikim searchforclinicalgeneticmorphologicalandimmunohistochemicalpredictorsofparathyroidcancerrecurrence
AT annakeremkina searchforclinicalgeneticmorphologicalandimmunohistochemicalpredictorsofparathyroidcancerrecurrence
AT alinarelfimova searchforclinicalgeneticmorphologicalandimmunohistochemicalpredictorsofparathyroidcancerrecurrence
AT nataliagmokrysheva searchforclinicalgeneticmorphologicalandimmunohistochemicalpredictorsofparathyroidcancerrecurrence